# Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

> **NCT00506129** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 33 (actual)

## Conditions studied

- Lymphoma
- Disorder Related to Bone Marrow Transplantation

## Interventions

- **DRUG:** Fludarabine
- **DRUG:** Melphalan
- **PROCEDURE:** Allogeneic Transplant
- **DRUG:** Thymoglobulin

## Key facts

- **NCT ID:** NCT00506129
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2020-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00506129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00506129, "Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00506129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*